|1.||Sölétormos, G: 5 articles (03/2004 - 05/2000)|
|2.||Liska, Vaclav: 3 articles (05/2012 - 03/2009)|
|3.||Dombernowsky, P: 3 articles (03/2004 - 05/2000)|
|4.||Buccheri, Gianfranco: 3 articles (09/2003 - 06/2003)|
|5.||Ferrigno, Domenico: 3 articles (09/2003 - 06/2003)|
|6.||Petersen, P H: 3 articles (11/2001 - 05/2000)|
|7.||El Khoudary, Samar R: 2 articles (11/2013 - 10/2011)|
|8.||Matthews, Karen A: 2 articles (11/2013 - 10/2011)|
|9.||Treska, Vladislav: 2 articles (05/2012 - 04/2011)|
|10.||Holubec, Lubos: 2 articles (05/2012 - 04/2011)|
01/01/1978 - "Tissue polypeptide antigen (TPA): Biology, biochemistry, improved assay methodology, clinical significance in cancer and other conditions, and future outlook."
08/01/2003 - "To evaluate the sensitivity and specificity of serum tissue polypeptide antigen (TPA) as a tumor marker for monitoring tumor recurrence in a prospective Phase II study. "
01/01/1992 - "[A clinical study of the significance of the gradient between feeding arterial tissue polypeptide antigen (TPA) and draining venous TPA in assessing the risk for recurrent breast cancers]."
10/01/1989 - "[Immunohistochemical study of tissue polypeptide antigen (TPA) in human urinary bladder tumors]."
12/01/1988 - "[Clinical studies on the measurement of urinary tissue polypeptide antigen (TPA) levels using Prolifigen TPA kit "Daiichi"-II in urothelial cancers]."
|2.||Breast Neoplasms (Breast Cancer)
07/01/1985 - "[Clinical study of the measurement of tissue polypeptide antigen in patients with breast cancer]."
01/01/1997 - "Levels of CA15.3 and tissue polypeptide antigen using the M3 monoclonal antibody (TPS) were determined in the serum of 60 patients with metastatic breast cancer. "
01/01/1992 - "Tissue polypeptide antigen in breast cancer cytosol: a new effective prognostic indicator."
01/01/1989 - "20 female with breast cancer aged between 44 and 72 years have been investigated for tissue-polypeptid-antigen (TPA). "
01/01/1989 - "[Detection and significance of tissue polypeptide antigen (TPA) in breast cancer patients]."
|3.||Urinary Bladder Neoplasms (Bladder Cancer)
07/01/1996 - "Tissue polypeptide antigen is a useful marker not for the early detection of bladder cancer but for the monitoring of the efficacy of a treatment."
09/01/2010 - "The aim of this study is to determine the clinical value of serum tissue polypeptide antigen (TPA) as a tumour marker for urinary bladder cancer in comparison with conventional urine cytology. "
12/01/1988 - "[Improvement of the determination of urinary tissue polypeptide antigen (TPA) and the clinical study in bladder cancer patients]."
01/01/1988 - "III. Immunohistochemical study of tissue polypeptide antigen (TPA) in bladder tumors]."
12/01/1981 - "A 2-stage study has been carried out to evaluate the usefulness of urinary tissue polypeptide antigen (TPA) levels in patients with bladder cancer as an adjunct to the routine procedures for detection of bladder tumours. "
09/01/1993 - "Clinical evaluation of tissue polypeptide antigen (TPA) in the diagnosis of pancreatic carcinoma."
01/01/1993 - "Prognostic significance of tissue polypeptide antigen (TPA) in head and neck carcinomas."
04/01/1990 - "[Blood and urine determinations of tissue polypeptide antigen in patients with bladder carcinoma]."
11/01/1989 - "On the contrary the tissue polypeptide antigen was detected in a considerable number of neoplastic cells in the poorly differentiated carcinomas as well as in the fields with basal and cylindric cells. "
01/01/1989 - "Urine-Tissue Polypeptide Antigen (U-TPA) was measured in 81 patients with a previously diagnosed bladder carcinoma. "
06/01/1996 - "In stroke patients, high TPA antigen concentrations may indicate an activation of the fibrinolytic system or may be due to a delayed clearance of TPA complexed with inhibitors. "
01/01/1999 - "This population-based case-control study shows that elevated plasma tPA antigen level is independently associated with an increased risk for ischemic stroke in nondiabetic females 15 to 44 years of age. "
01/01/1999 - "Mean plasma tPA antigen levels were significantly higher in stroke patients than control subjects (4. 80+/-4.18 versus 3.23+/-3.67 ng/mL; P=0.015). "
04/16/1994 - "This prospective study shows that high concentrations of tPA antigen among apparently healthy men are independently associated with high risks of future stroke, especially thromboembolic stroke. "
10/01/1998 - "In this study, the normal distribution of tPA antigen was determined in several stroke-prone regions in the rat brain often used to study the pathophysiological consequences of cerebral ischemia. "
|3.||Keratin-19 (Keratin 19)
|6.||Biological Tumor Markers (Tumor Markers)
|7.||squamous cell carcinoma-related antigen
|8.||Tissue Plasminogen Activator (Alteplase)
|9.||Phosphopyruvate Hydratase (Enolase)
|10.||Biological Markers (Surrogate Marker)
|2.||Drug Therapy (Chemotherapy)